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Abstract
Matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) is now widely used for marker/multi-
biomarker detection in medical diagnosis. We tested a new protocol for bacterial identiﬁcation from blood culture broths in hospital
routine by using collection tubes with separator gels on 503 included samples examined over 3 months, where 1.5 mL was injected by
a syringe into BD Vacutainer tubes from BACTEC-positive bottles, before processing for bacterial protein extraction. Samples were
loaded in duplicate onto the MALDI MS target, allowing a series of 12 samples to be processed in duplicate within 80 min by using
Biﬂex III and BioTyper 2.0 software (Bruker). Including polymicrobial samples, 193 of 213 of Gram-negative bacteria (91.08%) and 284
of 319 of Gram-positive bacteria (89.02%) were correctly identiﬁed at the species level. Enterobacteriaceae constituted 35.15% of all spe-
cies found, Staphylococaceae 37.96%, Streptococaceae and Enterococaceae 20.85%, Pseudomonadaceae 1.69%, and anaerobes 2.44%. In most
of the polymicrobial samples, one of the species present was identiﬁed (80.9%). Seven isolates remained misidentiﬁed as Streptococcus
pneumoniae, all belonging to Streptococcus mitis. Staphylococcus aureus was identiﬁed better when grown on anaero-aerobic medium, and
MALDI BioTyper identiﬁcation scores as low as 1.4 were pertinent, provided that four successive proposals of the same species were
given. This new protocol correlates with conventional microbiology procedures by up to 90%, and by >95% for only monomicrobial
samples, and provides a decreased turn-around time for identiﬁcation of bacteria isolated from blood cultures, making this technology
suitable also for blood cultures, with less delay and cost decreases in bacterial diagnostics, and favouring better care of patients.
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Introduction
Sepsis is related to multiple organ dysfunction, with a high
mortality rate (10–40%), and requires microbiological tests
to establish bacteraemia by using blood culture (BC) [1]. The
presence of microorganisms in the bloodstream is diagnosed
in only 4–12% of all BCs in hospitals, with sometimes false-
negative results, and up to 65% of intensive-care patients
showing symptoms of sepsis are already under presumptive
antimicrobial treatment. Thus, rapid bacterial diagnosis would
sometimes enable more appropriate therapy [2]. Automated
BC techniques have considerably increased the performance
of bacterial analyses as compared with classical techniques,
and media have evolved considerably over the past 30 years
[3,4]. Few delays are requested for positive BCs, and other
days remain to be resolved for the processing of identiﬁca-
tion, based on phenotypic features, from enriched cultures.
A number of analytical methods may now be used for the
detection and identiﬁcation of bacteria, but may take several
days to identify the pathogen. Therefore, rapid bacterial
identiﬁcation from BCs, which may inﬂuence both presump-
tive antimicrobial therapy and antimicrobial susceptibility
testing, remains a challenge [5]. Wide research efforts are
being made to solve this problem and to ﬁnd ways of
improving identiﬁcation, especially for sepsis cases; examples
are PCR [3], ﬂuorescence in situ hybridization and high-
throughput DNA sequencing [3,4,6,7].
Matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry (MS) allows identiﬁcation
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of most of the pathogenic bacteria grown on agar plates
from isolated colonies within a few minutes, and has proven
efﬁciency and reproducibility [8–13]. Plasma represents up to
55% of the total blood volume, and offers a good opportu-
nity to recover grown bacteria [14], as they are mostly pres-
ent in the extracellular compartment. In this study, we
compared MALDI-TOF MS with conventional methods by
injecting 1.5 mL of positive BC medium into serum separator
tubes, and using a new protocol for bacterial separation.
Protein extraction from recovered bacteria was a prerequi-
site for MALDI-TOF BioTyper-assisted bacterial identiﬁcation
following new rules.
Materials and Methods
Samples
Blood specimens from adult patients were systematically
collected on BACTEC containing anaerobic (BACTEC anaero-
bic (BAA)) or aerobic (BACTEC aerobic (BA)) resins. Bottles
containing 8–12 mL of whole blood were incubated in
BACTEC 9240 instruments (Becton Dickinson, Meylan,
France) for 5-day for the standard incubation protocol or less
if a positive signal was detected. Nine paediatric bottles were
included in this study. The direct identiﬁcation of bacteria from
both positive aerobic (BA) and anaerobic (BAA) bottles by
MALDI-TOF MS was performed serially in parallel with the
routine protocol for 5 days a week over a 13-week period at
the laboratory of bacteriology of Strasbourg University Hospi-
tal from 15 December 2008 to 22 December 2008 and from
12 January 2009 to 1 March 2009, and for another period from
1 April 2009 to 7 May 2009, for staff reasons and to overlap
several seasons. After subculture on agar plates, any positive
BC was simultaneously treated for bacterial identiﬁcation with
conventional procedures, including Vitek II cards or API
galleries (BioMe´rieux, Craponne, France), and, if necessary,
with complementary individual biochemical or enzymatic tests.
Separation (blood cells and bacteria) and protein extraction
protocol
Approximately 1.5 mL was recovered from positive BC vials,
and injected with a syringe into either Clot activator and gel
BD Vacutainer tubes (n = 166) (Becton Dickinson) or Z
Serum Sept Clot Activator (n = 400) (Greiner Bio One,
Courtaboeuf, France). Tubes were centrifuged at 500 g for
10 min at room temperature (RT) to separate blood cells at
the bottom of the gel from plasma and cell debris and bacte-
ria at the surface. Bacterial sediment was suspended in
1.5 mL of sterile water, transferred to an Eppendorf micro-
tube, and centrifuged at 300 g for 1 min at RT for better
removal of cell debris still present; this differs from previous
protocols [15,16]. One microlitre of this supernatant was
transferred to another microtube to collect bacteria after a
10 000 g centrifugation for 2 min at RT.
The bacterial pellet was treated with the standard ethanol/
formic acid protein extraction protocol for MALDI-TOF MS
identiﬁcation [12]. One microlitre of protein extract was then
loaded in duplicate into wells of a polished steel TF MTP 384
target plate (Bruker Daltonics, Bremen, Germany), covered
with 1.5 lL of a saturated solution of a-cyano-4-hydroxycin-
namic acid/MALDI-TOF matrix in 50% (v/v) acetonitrile/2.5%
(v/v) triﬂuoroacetic acid as an electron donor.
MALDI-TOF MS parameters and bacterial identiﬁcation
All mass spectra were acquired with a Biﬂex III MALDI-TOF
mass spectrometer (Bruker Daltonics) with a nitrogen laser
(337 nm, 3 mW, 10 MHz) operated in the positive linear
mode (delay 400 ns, voltage 20 kV, mass range 2–20 kDa),
and integrated with Flex Control 3.0 software (Bruker Dal-
tonics). Initial laser shots with relatively high energy (40%) to
‘clean the matrix’ (matrix blast effect) were performed. The
laser energy was then decreased (20%) until the signals disap-
peared, to generate the desired spectrum after smoothing,
baseline subtraction, normalization, and peak picking [12].
Each spectrum was obtained as described previously [9].
Spectrum ﬁles were transferred to BioTyper Automation
Control 2.0 (Bruker Daltonics) software, which compares
the obtained spectrum with the spectra database (MALDI
BioTyper DB Update_2.0.4.0; 3290 entries, 1960 microorgan-
ism species; Bruker Daltonics). Escherichia coli DH5a was used
as a ‘positive control’ for correct sample preparation, correct
instrument tuning and, especially, for correct calibration to
avoid even small differences in spectrum generation. E. coli
was prepared with the same sample preparation protocol as
used for the other samples. Calibration was performed with
six constant and major proteins, including a peak at
10 299.09 Da, and two additional proteins, RNase A
(13 683.2 Da) and myoglobin (16 952.3 Da) (Bruker Daltonics
recommendations). The mass accuracy after external calibra-
tion with known E. coli protein signals was about 500 p.p.m.
Spectrum quality criteria were as follows: high spectrum
reproducibility, little noise and a ﬂat baseline (signal-to-noise
ratio above 15), presenting as many peaks as possible (maxi-
mum = 300), and an averaged resolution of 600 (M/DM)
within the range of m/z selected for analysis (2000–
20 000 Da).
From the cumulative data comparison of the unknown
spectrum and a best-ﬁtting given spectrum in the library, a
ﬁnal log score value for the unknown spectrum was calcu-
lated, ranging from 0 to 3, representing the reliability of the
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identiﬁcation. For identiﬁcation of bacterial colonies on agar
plates, BioTyper recommendations are that score values
should be divided into three intervals: a log score ‡2.0 is
mainly considered to be the threshold for a match at the
species level [12], 1.7–2.0 indicates a close relationship (at
least at the genus level), and <1.7 indicates identiﬁcation of
unknown reliability. However, for BCs, varying bacterial den-
sities and bacterial yields may lead to the use of different
rules, such as the consecutive proposed identiﬁcations, when
similar. The total time needed to perform the whole bacte-
rial identiﬁcation process for 12 samples loaded in duplicate
was 80 min.
Results
During a 3-month period, we tested 566 blood samples orig-
inating from anaerobic, aerobic and paediatric blood vials.
For this comparison of MALDI-TOF MS results with those
obtained by routine techniques, 28 bacteria were discarded
from the overall study, as routine techniques only provided
identiﬁcation at the genus level, and they were considered to
be contaminants. MALDI-TOF Biotyper was able to identify
all of these specimens at the species level (mainly Staphylococ-
cus epidermidis and other coagulase-negative staphylococci
(CoNS)). All included samples were treated under the same
conditions. Eleven yeasts identiﬁed by routine techniques
were also excluded, because the study was focused only on
bacterial identiﬁcation. Twenty-four negative BCs were also
tested in a blind manner throughout the study. They all were
all negative with MS identiﬁcation.
For the remaining 503 samples issued from 378 patients,
532 bacteria were identiﬁed with usual techniques corre-
sponding to the synthetic identiﬁcations obtained from BC
BAA or BA broths, when available (Table 1). MALDI BioTyper
never provided contradictory results from BA and BAA
TABLE 1. List of microorganisms
identiﬁed with standard methods
and with MALDI BioTyper 2.0
from 503 blood cultures during the
study period
Microorganisms
All samples
(identiﬁed
with standard
methods)
Monomicrobial
isolates identiﬁed
with MALDI-TOF MS/
identiﬁed with
standard methods
Polymicrobial
isolates identiﬁed
with MALDI-TOF MS/
identiﬁed with
standard methods
Gram-positive bacteria (284/319 identiﬁed)
Staphylococcus epidermidis 123 115/118 3/5
Staphylococcus aureus 50 47/49 0/1
Other coagulase-negative
Staphylococci
29 21/25 1/4
Enterococcus faecalis 29 22/22 3/7
Enterococus faecium 6 4/4 2/2a
Streptococcus pneumoniae 38 36/37 1/1
Streptococcus disgalactiae 12 12/12 0
Streptococcus pyogenes 10 10/10 0
Streptococcus agalactiae 6 6/6 0
Streptococcus mitisb 6 0/5 0/1
Streptococcus anginosus 1 1/1 0
Streptococcus oralis 1 0/1 0
Streptococcus sanguinis 1 0/1 0
Streptococcus vestibularis 1 0 0/1
Propionibacterium acnes 4 0/4 0
Clostridium sp. 2 0 0/2
Gram-negative bacteria (193/213 identiﬁed)
Escherichia coli 114 105/106 4/8a
Klebsiella pneumoniae 24 24/24 0
Enterobacter cloacae 19 15/16 1/3a
Klebsiella oxytoca 8 8/8 0
Serratia marcescens 8 8/8 0
Citrobacter freundii 6 3/3 1/3
Enterobacter aerogenes 6 6/6 0
Proteus mirabilis 1 1/1 0
Salmonella sp. 1 0 0/1
Acinetobacter baumanii 5 1/1 2/4a
Acinetobacter junii 1 0 0/1
Neisseria meningitidis 1 1/1 0/0
Pseudomonas aeruginosa 8 7/7 0/1
Stenotrophomonas maltophilia 3 0 0/3
Pseudomonas putida 1 1/1 0
Bacteroides fragilis 6 5/5 0/1
Bacteroides ovatus 1 0 0/1
Blind negative controls (24)
Total 532c 459/482 (95.22%) 18/50 (36%)
MALDI-TOF MS, matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry.
Number of bacteria correctly identiﬁed: polymicrobial samples included 477/532 (89.66%). No negative control pro-
duced a signiﬁcant mass spectrum (no reliable identiﬁcation).
aFour isolates were, in fact, identiﬁed at scores <1.4, and were not taken into account.
bStreptococcus mitis misidentiﬁed as Streptococcus pneumoniae.
cOnly isolates (without 24 negative controls).
CMI Moussaoui et al. MALDI-TOF and bacterial blood cultures 1633
ª2010 MALDI Biotypes
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 1631–1638
cultures, and identiﬁed 477 of these 532 bacterial isolates,
representing a percentage of 89.66% of correct whole bacte-
rial identiﬁcation as compared with conventional methods,
including 21 polymicrobial samples. Among the 477 bacterial
strains identiﬁed by MALDI BioTyper, 378 were identiﬁed with
a high score (from 1.9 to 2.7), and 71 were identiﬁed with a
lower average score (from 1.7 to 1.9). However, 28 bacteria
were correctly identiﬁed by taking into account the succession
of at least four identical proposals of identiﬁcation given by
BioTyper 2.0 for at least four distinct database strains of a
given species, provided that these scores were all >1.43–1.40.
In such conditions, any identiﬁcation with four or more identi-
cal proposals was a correct one, whereas those with scores
<1.35 were mainly not correct or random. These 28 bacteria
identiﬁed with a lower score were ﬁve S. epidermidis, four
other CoNS, eight Staphylococcus aureus (grown in BAA), four
Streptococcus pneumoniae, two Streptococcus pyogenes, one
Streptococcus dysgalactiae, two E. coli, one Enterobacter cloacae,
and one Acinetobacter junii. Thus, such a procedure improves
correct identiﬁcation for almost 6%.
The 477 correctly identiﬁed samples were distributed as
follows: 187/202 Staphylococcaceae, 176/187 Enterobacteria-
ceae, 66/76 Streptococcaceae, 31/35 Enterococaceae, 8/9 Pseud-
omonaceae, 5/13 anaerobes, and 4/10 remaining isolates
(Table 1). The 21 polymicrobial samples corresponded to 50
bacteria identiﬁed by conventional techniques. Thus, 482
monomicrobial BCs led to 459 correct MALDI BioTyper
identiﬁcations, i.e. 95.22%.
Monomicrobial BCs (482 samples)
The 459 correct BioTyper identiﬁcations were distributed
among different bacterial groups as follows: Enterobacteriaceae,
170/172 (98.84%); Pseudomonaceae, 8/8 (100%); Acinetobacter
baumanni, 1/1; and Neisseria meningitidis, 1/1; Staphylococcaceae,
183/192(95.31%); enterococci, 26/26(100%),; Streptococcaceae,
65/73 (89.04%); and anaerobes, 5/9 (44.44%) (see Table 1).
Gram-negative microorganisms (187 bacteria)
The usual rank order of frequency in bacteraemias from
teaching hospitals for Enterobacteriaceae is as follows:
E. coli > Klebsiella spp. > Serratia spp. > Enterobacter
spp. = Proteus spp. > others [17]. Here, a similar rank order
was observed; E. coli, with 105/106 isolates correctly identi-
ﬁed, constitutes the predominant species found among
Enterobacteriaceae (170/172). The other Enterobacteriaceae
were also correctly detected: Klebsiella pneumoniae, 24/24;
Enterobacter cloacae, 15/16; Serratia marcescens, 8/8; Klebsiella
oxytoca, 8/8; Citrobacter freundii, 3/3; Enterobacter aerogenes,
6/6; and Proteus mirabilis, 1/1. Concerning non-fermenting
species, 7/7 Pseudomonas aeruginosa and 1/1 Pseudomonas
putida strains were correctly identiﬁed at the species level,
with high score values. One sample containing A. baumanii
and one containing N. meningitidis were identiﬁed. Further-
more, Gram-negative anaerobes were correctly detected,
here 5/5 Bacteroides fragilis. Overall, 98.93% (185/187) of
Gram-negative bacteria were correctly identiﬁed in monomi-
crobial samples.
Gram-positive microorganisms (295 bacteria)
The most frequently detected bacterium in BCs was S. epide-
rmidis [3]. It was detected in 115/118 isolates, despite the
fact that it is known to grow more slowly in BC than other
Gram-positive organisms. Forty-seven of 49 isolates were
correctly identiﬁed as S. aureus, when grown on BAA med-
ium. When S. aureus was grown on BAA medium, 25 and 14
isolates were identiﬁed with scores of >1.9 and >1.7, respec-
tively, whereas eight other samples were identiﬁed as S. aur-
eus with succession scores >1.45. For the same samples
incubated in BA medium, only four isolates were identiﬁed
with scores >1.9, 11 with scores >1.7, and two with scores
>1.45 where four identical and successive species were
proposed. The difference between scores for the two
culture conditions was statistically signiﬁcant (Student’s t-test,
p <0.05). The remaining CoNS were correctly identiﬁed in
21/25 cases by MALDI Biotyper. Overall, nine Staphylococca-
ceae strains were unidentiﬁed by MALDI BioTyper, mainly
because of the lower level of bacterial culture or difﬁculty in
the protein extraction procedure, such as poor separation of
blood cells, which remained in contact with bacteria on the
separator gel, or because the separator gel did not adhere
sufﬁciently to the tubes.
Various Streptococcus species were also detected (65/73) in
this series: 36/37 Streptococcus pneumoniae, 12/12 Streptococcus
disgalactiae, 10/10 Streptococcus pyogenes, 6/6 Streptococcus
agalactiae, 1/1 Streptococcusanginosus, and 0/1 Streptococcus
sanguinis. Streptococcus mitis (0/5) and Streptococcus oralis (0/
1) were misidentiﬁed by this technique as Streptococcus
pneumoniae. Enterococci were all correctly distinguished:
22/22 Enterococcus faecalis and 4/4 Enterococcus faecium.
Gram-positive anaerobes in monomicrobial samples were
only represented by unidentiﬁed Propionibacterium acnes
(0/4). MALDI- BioTyper correctly identiﬁed 274/295 (92.88%)
Gram-positive bacteria. Thus, 95.22% of monomicrobial
isolates were identiﬁed in these 482 samples. Most of the
poorly identiﬁed Gram-positive bacteria belonged to CoNS
and to Streptococcus (seven and ten isolates, respectively).
Polymicrobial blood cultures
Twenty-one polymicrobial samples generated 50 isolates by
routine classical identiﬁcation (Table 2). MALDI-TOF MS
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identiﬁcation used the same procedure, but bacteria were
identiﬁed by considering the ten identiﬁcation proposals
provided by Biotyper. In fact, polymicrobial samples were
suspected when MALDI BioTyper proposed two alternative
species that were identiﬁed with score values >1.7. Table 3
shows that, for samples containing two or more species,
BioTyper identiﬁcation may give iterated, but mixed, propos-
als of two distinct species, but with signiﬁcant scores
presumably according to the relative abundance of each bac-
terium. For such cases, BioTyper allows the superimposition
and comparison of the sample spectrum with library spectra
(Fig. 1). It is then possible to further analyse the different
proposals. Among polymicrobial samples, 15 had two grow-
ing species identiﬁed with standard methods (Table 2). For
these samples, MS identiﬁed one species in 12 of the cases.
For eight of these samples, scores were >1.9, two others
were correctly identiﬁed with a >1.7 score, and two were
identiﬁed with a >1.4 score. However, two bimicrobial sam-
ples gave correct identiﬁcation of three bacteria at scores
<1.4; they were not considered. Nevertheless, identiﬁcation
proposals by BioTyper may become random with a lower
cut-off. We always obtained at least one correct identiﬁca-
tion for the four trimicrobial samples, where ﬁve bacteria
were identiﬁed with scores >1.7, except for one with a
TABLE 2. The 21 polymicrobial
samples identiﬁed by both meth-
ods (conventional methods and
MALDI BioTyper 2.0)
Standard method identiﬁcation
MALDI BioTyper
identiﬁcation Score value
Escherichia coli + Staphylococcus epidermidis E. coli 2.021
Enterococcus faecalis + CoNS Enterococcus faecalis 2.145
Enterococcus faecium + Streptococcus mitisa Enterococcus faecium +
Streptococcus pneumoniaea
1.777–1.760
Enterococcus faecalis + Staphylococcus aureus Enterococcus faecalis 2.213
Enterococcus faecalis + Escherichia coli Enterococcus faecalis 2.036
Staphylococcus epidermidis + Enterococcus faecalis S. epidermidis 1.948
Enterococcus faecium + CoNS Enterococcus faecium 2.403
S. epidermidis + E. coli S. epidermidis 1.740
S. epidermidis + E. coli S. epidermidis 2.021
Streptococcus pneumoniae + Salmonella sp. Streptococcus pneumoniae 1.695
Enterobacter cloacae + Acinetobacter baumannii Enterobacter cloacae 1.535
A. baumanii + Enterobacter cloacae A. baumanii 1.316b
E. coli + Enterococcus faecalis E. coli, Enterococcus faecalis 1.321–1.2b
Bacteroides fragilis + CoNS No reliable identiﬁcation –
Bacteroides ovatus + S. epidermidis No reliable identiﬁcation –
Staphylococcus hominis + Staphylococcus vestibularis + Acinetobacterjunii S. hominis 1.675
A. baumannii + Citrobacter freundii + Stenotrophomonas maltophilia A. baumannii 1.930
C. freundii + A. baumannii + Stenotrophomonas maltophilia C. freundii, A. baumannii 1.993–1.757
E. coli + Enterococcus faecalis + Clostridium spp. E. coli 1.962
E. coli + Enterobacter cloacae + Pseudomonas aeruginosa +
Stenotrophomonas maltophilia
E. coli 2.149
E. coli + C. freundii + Clostridium spp. + Enterococcus faecalis E. coli 2.168
CoNS, coagulase-negative staphylococci.
aMisidentiﬁcation at the species level.
bID scores <1.4 were not taken into account, despite correct identiﬁcation.
TABLE 3. MALDI BioTyper 2.0 identiﬁcations: examples of proposals given for a monomicrobial sample and for two poly-
microbial samples
ID Rank
Monomicrobial example:
Escherichia coli
Polymicrobial example: E. coli and Klebsiella
pneumoniae
Polymicrobial example: E. coli
and Clostridium perfringens
1 E. coli ATCC 25922
Score: 2.499
K. pneumoniae ssp. pneumoniae 9295_1
Score: 2.106
E. coli ATCC 35218
Score: 1.758
2 E. coli DH5a
Score: 2.369
E. coli ATCC 35218
Score: 2.104
C. perfringens ATCC 3626
Score: 1.658
3 E. coli MB11464_1
Score: 2.352
E. coli MB11464_1
Score: 1.964
E. coli ESBL_EA_RSS1528T
Score: 1.632
4 E. coli DSM 30083T
Score: 2.295
K. pneumoniae 37585 PFM
Score: 1.867
C. perfringens NCTC 4964
Score: 1.628
5 E. coli ATCC 25921
Score: 2.273
K. pneumoniae ssp. pneumoniae DSM 30104T
Score: 1.855
E. coli MB11464_1
Score: 1.611
6 E. coli NISSL
Score: 2.265
E. coli B421
Score: 1.848
C. perfringens NCTC 8346
Score: 1.608
7 E. coli SBL_EA_RSS_1528
Score: 2.174
K. pneumoniae ssp. ozaaenae DSM 16358
Score: 1.817
C. perfringens NCTC 8237
Score: 1.564
8 E. coli ATCC 35218
Score: 2.156
E. coli ATCC 2592
Score: 1.811
E. coli B421
Score: 1.531
9 Escherichia fergusonii DSM 1369
Score: 2.106
K. pneumoniae ssp. rhinoscleromatis DSM 16231
Score: 1.776
C. perfringens NCTC 3110
Score: 1.461
10 Escherichia albertii DSM 17582T
Score: 2.099
K. pneumoniae 37595PFM
Score: 1.763
E. coli ATCC 25922
Score: 1.412
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score of 1.675 (Table 2). No reliable identiﬁcation was
obtained for a bimicrobial sample and the single quadrimicro-
bial sample. All Stenotrophomonas maltophilia strains that were
found only in polymicrobial samples remained unidentiﬁed.
Finally, MALDI BioTyper identiﬁed 18 bacteria, 8/25 Gram-
negative and 10/25 Gram-positive, respectively, according to
the rules established in this study.
Overall, MS succeeded in identifying 89.66% (477/532) of
the bacteria identiﬁed by conventional procedures, contained
in 503 BC samples.
Discussion
Even though BC is considered to be the reference standard
for the detection of microorganisms in blood samples [2], it
remains dependent on different factors, such as bacterial den-
sity [18], bacterial adaptation to new growth environments,
individual rates of growth, competition between bacteria, and
initial antimicrobial therapy. The delay in identiﬁcation mostly
remains unsatisfactory for clinicians, who often initiate
presumptive antimicrobial therapy prior to precise diagnosis.
Shortening the delay in providing dedicated therapy may
strengthen its speciﬁcity, and would have a beneﬁcial effect
on the recovery of patients [3]. Because of the high sensitivity
of MS in detecting peptides and the possibility of identifying
bacteria with software such as Biotyper, it has been possible
to demonstrate the high quality of identiﬁcation [12].
Here, we propose a new protocol and rules for the iden-
tiﬁcation of bacteria from BCs with MALDI-TOF BioTyper,
which allowed 89.66% correct and single-step identiﬁcations
among a total of 532 microorganisms from 503 blood sam-
ples, including polymicrobial samples from small volume of
BC. Monomicrobial samples were correctly identiﬁed at the
species level in 95.22% of cases. All bacteria were identiﬁed
within the 2–3 h following BC positivity. The largest series
consisted of 16 daily consecutive samples. Using a Vacutainer
tube containing 1 mL of separation gel and two low-speed
centrifugations from no more than 1.5 mL of BC, we
observed better separation of bacteria from blood cells and
more accurate bacterial identiﬁcation than is possible with
some published procedures which makes it difﬁcult applying
these to paediatric blood cultures [16,19,20]. In such an
approach, a low level of bacteria and contamination by blood
components may alter the stereotypes of bacterial protein
spectra, and full adhesion of gel to tube walls is obligatory
for good separation and recovery of bacteria. Protein extrac-
tion remains obligatory. Some authors have attempted more
direct protein extraction, even from low volumes of BC, but
have mainly obtained lower correct identiﬁcation rates at
the species level [11,15,21], or have needed more time, e.g.
incubation with saponin treatment and with enrichment
broth for 12% of BCs [15,21]. Gel separator Vacutainer
tubes seem to be a good compromise for rapid and accurate
bacterial identiﬁcation with MS. With respect to other, more
rapid, protein extraction protocols, we prefer to spend
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FIG. 1. Identiﬁcation of polymicrobial
results displayed within the BioTyper
2.0 graphic view. The mass spectra
shows the difference in peaks (presence
or absence) and their intensity between
the sample spectrum and those of bac-
teria identiﬁed at ﬁrst proposals. The
upper part of the ﬁgure within the inner
windows shows the unknown spectrum
containing perfectly matching peaks (0–
200 p.p.m.) in green, imperfectly match-
ing peaks (200–500 p.p.m.) in yellow,
and non-matching peaks in red. The
lower part (blue) shows the dedicated
main spectrum included in the database.
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more time on protein extraction and obtain better bacterial
identiﬁcation from BCs.
As observed earlier, BioTyper sometimes proposes
correct identical identiﬁcations with scores lower than 1.9 or
1.7, but with identical successive proposals. We decided to
take them into account when four successive proposals
referred to different strains of a single species. Thus, when
four successive proposals with ﬁrst scores >1.4 were given
for BCs, species identiﬁcation for BCs was never false in this
series. The low or varying amounts of bacteria recovered
here may have an impact on the intensity of peaks that may
allow adaptation to previous recommendations [21]. In this
study, the proposed rules that consider successive proposals
with scores between 1.4 and 1.7 allow identiﬁcation of 5.2%
more bacteria.
For polymicrobial samples, mixed proposals of two bacte-
ria may be observed with signiﬁcant scores (Table 3), but in
the case of blood samples, attention will be given to check at
the next isolation plate grown for antimicrobial susceptibility,
for further bacterial identiﬁcation if necessary. This may help
to validate the initial status of blood samples, if not precluded
earlier by Gram staining. In this work, BC did not contain
charcoal which was recently referred as less favourable [22].
Those blood samples from adults were systematically cultured
in both BAA and BA medium, whereas we included nine BCs
from paediatric bottles with only one P. acnes unidentiﬁed.
Stenotrophomonas maltophilia, which was encountered
only in polymicrobial cultures in this work, was not identi-
ﬁed. P. acnes was another bacterium that was never identi-
ﬁed by BioTyper 2.0 during the study period. Since this
time, the library of spectra has been improved, and allows
such identiﬁcation. There was no misidentiﬁcation for
Streptococcus pneumoniae, but Streptococcus mitis/oralis samples
were misidentiﬁed as Streptococcus pneumoniae. This problem,
already noted [15,19], is more related to the quality of
spectra resulting in difﬁculty in segregating the three species
Streptococcus mitis, Streptococcus oralis and Streptococcus
pneumoniae. Such identiﬁcation may be achieved with further
plate culture by testing the Optochine sensitivity or bile
solubility. Incubation in BAA medium as compared with BA
medium signiﬁcantly improved the quality of spectra and
identiﬁcation of staphylococci, especially S. aureus (p >0.5).
Spectra from Staphylococcus species remain quite scarce as
compared with those from other bacteria, such as Enterobac-
teriaceae, and low amount of material may rapidly impact on
the quality of identiﬁcation. In two recent studies, identiﬁca-
tion of S. aureus remained quite poor, with averages of 78%
[16] and 76% [11], whereas other authors have reported
a better ratio of 90% [21,23] when considering low
scores >1.5, but not successive proposals. These last authors
suggested that bacterial counts should be between 107 and
2 · 109 CFU to ensure good identiﬁcation, whereas lower
or greater counts would not be as satisfactory. Ferroni et al.
[15] used a two-step consideration of proposals, and
established a 60% matching deﬁned by their system, which
stipulates that the second proposal gives 50% matching at
least to conﬁrm species identiﬁcation; if not, secondary
identiﬁcation of species group, genus, family was considered.
Christner et al. [21] considered BioTyper scores >1.5 as
being critical for the identiﬁcation of 8% of the isolates,
but without considering polymicrobial samples. Nevertheless,
we observed some limits to the identiﬁcation of coagulase-
negative samples with such an approach. Thus, we propose
consideration of a succession of four proposals with ﬁrst
scores >1.4 for BC samples. This means that libraries would
have, in turn, to increase each species by at least four repre-
sentative strains.
In conclusion, we propose protein extraction and consid-
eration of score values of MS BioTyper for up to 90%
bacterial identiﬁcation from whole monomicrobial and
polymicrobial BC samples. This rapid identiﬁcation allows
lower costs for laboratories and the use of a single approach
to identify a very large panel of bacteria, and will provide
better information to clinicians for dedicated antimicrobial
therapy, possibly contributing to a decrease in antimicrobial
pressure in hospitals.
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